share_log

Aerpio Pharmaceuticals shares are trading higher after HC Wainwright & Co. upgraded the company's stock from Neutral to Buy and announced a $22 price target.

Benzinga ·  Jul 8, 2021 09:18
Aerpio Pharmaceuticals shares are trading higher after HC Wainwright & Co. upgraded the company's stock from Neutral to Buy and announced a $22 price target.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment